Futura Strikes Deal To Commercialize Erectile Dysfunction Gel In Middle East

UK R&D firm Futura Medical strikes third commercial agreement for its drug-free erectile dysfunction treatment MED3000, this time with Switzerland’s Labatec Pharma, which will take the drug-free gel to the Middle East. 

Deal (Sergey Nivens/Shutterstock.com)
• Source: Shutterstock

More from Strategy

More from Business